Literature DB >> 18451249

Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Xiaochun Zhang1, Ritsuko Komaki, Li Wang, Bingliang Fang, Joe Y Chang.   

Abstract

PURPOSE: Radioresistance may be caused by cancer stem cells (CSC). Because CSCs require telomerase to proliferate, a telomerase-specific oncolytic adenoviral vector carrying apoptotic tumor necrosis factor-related apoptosis-inducing ligand and E1A gene (Ad/TRAIL-E1) may preferentially target CSCs. EXPERIMENTAL
DESIGN: We established two pairs of parental and radioresistant (R) esophageal carcinoma cell lines (Seg-1, Seg-1R and TE-2, TE-2R) by fractionated irradiation. Stem cell markers were measured by Western blotting and flow cytometry. Serial sorting was used to enrich stem-like side population cells. Telomerase activity, transgene expression, antitumor activity, apoptosis induction, and viral replication were determined in vitro and/or in vivo.
RESULTS: Expression of the stem cell markers beta-catenin, Oct3/4, and beta(1) integrin in Seg-1R cells was 29.4%, 27.5%, and 97.3%, respectively, compared with 4.8%, 14.9%, and 45.3% in Seg-1 cells (P < 0.05). SP levels in Seg-1R and TE-2R cells were 14.6% and 2.7%, respectively, compared with 3.4% and 0.3% in Seg-1 and TE-2 cells. Serial sorting of Seg-1R SP cells showed enrichment of the SP cells. Telomerase activities in Seg-1R, Seg-1R SP, and TE-2R cells were significantly higher than in Seg-1, Seg-1R non-SP, and TE-2 cells, respectively (P < 0.05). Seg-1R and TE-2R cells were more sensitive to Ad/TRAIL-E1 than parental cells. Increased Coxsackie-adenovirus receptor and elevated transgene expressions were found in the radioresistant cells. Ad/TRAIL-E1 resulted in significant tumor growth suppression and longer survival in Seg-1R-bearing mice (P < 0.05) with no significant toxicity.
CONCLUSION: Radioresistant cells established by fractionated irradiation display CSC-like cell properties. Ad/TRAIL-E1 preferentially targets radioresistant CSC-like cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451249      PMCID: PMC2387204          DOI: 10.1158/1078-0432.CCR-07-1528

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

1.  Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.

Authors:  A S Pearson; P E Koch; N Atkinson; M Xiong; R W Finberg; J A Roth; B Fang
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

2.  beta1- and alpha6-integrin are surface markers on mouse spermatogonial stem cells.

Authors:  T Shinohara; M R Avarbock; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

3.  The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

Authors:  Tiffany M Phillips; William H McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2006-12-20       Impact factor: 13.506

4.  Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

Authors:  J Nichols; B Zevnik; K Anastassiadis; H Niwa; D Klewe-Nebenius; I Chambers; H Schöler; A Smith
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

5.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

6.  Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery.

Authors:  B Fang; L Ji; M Bouvet; J A Roth
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

8.  Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.

Authors:  Xiaochun Zhang; Rex Min Cheung; Ritsuko Komaki; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

Review 9.  Molecular and cellular insights into the coxsackie-adenovirus receptor: role in cellular interactions in the stem cell niche.

Authors:  Mathieu Hauwel; Emeline Furon; Philippe Gasque
Journal:  Brain Res Brain Res Rev       Date:  2005-04

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  46 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

Review 3.  Targeting cancer stem cells with oncolytic virus.

Authors:  Yin Tong; Wenbin Qian
Journal:  Stem Cell Investig       Date:  2014-11-28

4.  Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Authors:  Jian-Lin Wang; Jing-Ping Yu; Zhi-Qiang Sun; Su-Ping Sun
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.

Authors:  Xiaochun Zhang; Bingliang Fang; Radhe Mohan; Joe Y Chang
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

6.  Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation.

Authors:  Xiaochun Zhang; Steven H Lin; Bingliang Fang; Michael Gillin; Radhe Mohan; Joe Y Chang
Journal:  J Thorac Oncol       Date:  2013-12       Impact factor: 15.609

7.  Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Authors:  Han Hsi Wong; Nicholas R Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2010-01       Impact factor: 5.818

8.  TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.

Authors:  M R Loebinger; E K Sage; D Davies; S M Janes
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

Review 9.  Therapeutic strategies targeting cancer stem cells.

Authors:  Xiaoyan Ning; Jianchang Shu; Yiqi Du; Qiwen Ben; Zhaoshen Li
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

10.  TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.

Authors:  Sha Zhou; Shiliang Liu; Chuyong Lin; Yue Li; Liping Ye; Xianqiu Wu; Yunting Jian; Yuhu Dai; Ying Ouyang; Lei Zhao; Mengzhong Liu; Libing Song; Mian Xi
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.